Working with the Multidisciplinary Association for Psychedelic Studies (MAPS) for the past four years as their guest editor has been an extremely exciting and tremendously fruitful endeavor for me. It’s a great joy to see how MDMA can help people suffering from posttraumatic stress disorder (PTSD), how LSD can help advanced-stage cancer patients come to peace with the dying process, and how ibogaine can help opiate addicts overcome their addiction. There appears to be enormous potential for the development of psychedelic drugs into effective treatments for a whole range of difficult-to-treat psychiatric disorders.
However, as thrilled as I am by all the new clinical studies exploring the medical potential of psychedelic drugs, I still long for the day when our best minds and resources can be applied to the study of these extraordinary substances with an eye that looks beyond their medical applications, toward their ability to enhance human potential and explore new realities.
Latest posts by Trevor Smith (see all)
- The Benefits of Living Foods - Dec 14, 2013
- Rupert Sheldrake: Are Psychic Phenomena Illusory? - Jun 29, 2013
- Transcending the Medical Frontiers: Exploring the Future of Psychedelic Drug Research - Jun 18, 2013